DOPAMINE AND NOREPINEPHRINE REUPTAKE INHIBITOR (DNRI)
Sunosi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with excessive sleepiness associated with narcolepsy or obstructive sleep apnea. Sunosi is also known by its drug name, solriamfetol.
Sunosi belongs to a category of drugs called dopamine and norepinephrine reuptake inhibitors (DNRIs). Sunosi is believed to work by increasing the activity of dopamine and norepinephrine in the brain.
How do I take it?
Prescribing information states that Sunosi is taken once daily.
Sunosi comes in tablet form.
The FDA-approved label for Sunosi lists common side effects including headache, nausea, decreased appetite, anxiety, and problems sleeping.
Rare but serious side effects listed for Sunosi include blood pressure and heart rate increases and psychiatric symptoms.
For more details about this treatment, visit:
Sunosi — Jazz Pharmaceuticals